Clinical Trial Update: Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer. [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II study evaluating oral S-1 plus docetaxel for elderly patients with advanced gastric cancer has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Hokkaido Gastrointestinal Cancer Study Group | Conditions: Gastric Cancer | Phase 1, Phase 2 | Status: SUSPENDED